Here are five things to know about the patent:
1. The claims cover certain demineralized bone matrixes that contain minimum bone morphogenetic protein-2 levels.
2. The patent is titled “Process for Demineralization of Bone Matrix with Preservation of Natural Growth Factors.”
3. The company still has pending continuing applications in the United States that pursue protection on other aspects of the bone demineralization technology.
4. Bacterin was the first company commercializing a compressible DBM sponge marketed specifically for handling characteristics, osteoconductive architecture and osteoinductive prosperities for orthopedic bone grafting applications.
5. The company plans to continue innovating in this space.
More articles on orthopedic devices:
NuVasive, Integra LifeSciences, Orthofix & more—15 key notes
Zimmer launches XtraFix External Fixation System
Dr. Gabor Racz joins Stimwave board of directors—5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
